These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 33137926)

  • 1. DNA Associated with Circulating Exosomes as a Biomarker for Glioma.
    Vaidya M; Sugaya K
    Genes (Basel); 2020 Oct; 11(11):. PubMed ID: 33137926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of miRNA signatures in serum exosomes as a potential biomarker after radiotherapy treatment in glioma patients.
    Li Z; Ye L; Wang L; Quan R; Zhou Y; Li X
    Ann Diagn Pathol; 2020 Feb; 44():151436. PubMed ID: 31865249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA sequences within glioma-derived extracellular vesicles can cross the intact blood-brain barrier and be detected in peripheral blood of patients.
    García-Romero N; Carrión-Navarro J; Esteban-Rubio S; Lázaro-Ibáñez E; Peris-Celda M; Alonso MM; Guzmán-De-Villoria J; Fernández-Carballal C; de Mendivil AO; García-Duque S; Escobedo-Lucea C; Prat-Acín R; Belda-Iniesta C; Ayuso-Sacido A
    Oncotarget; 2017 Jan; 8(1):1416-1428. PubMed ID: 27902458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liquid Biopsy: Is There an Advantage to Analyzing Circulating Exosomal DNA Compared to cfDNA or Are They the Same?
    Kahlert C
    Cancer Res; 2019 May; 79(10):2462-2465. PubMed ID: 31043377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating glioma biomarkers.
    Kros JM; Mustafa DM; Dekker LJ; Sillevis Smitt PA; Luider TM; Zheng PP
    Neuro Oncol; 2015 Mar; 17(3):343-60. PubMed ID: 25253418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating Biomarkers for Glioma: A Review.
    Jones J; Nguyen H; Drummond K; Morokoff A
    Neurosurgery; 2021 Feb; 88(3):E221-E230. PubMed ID: 33442748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylated tumor-specific DNA as a plasma biomarker in patients with glioma.
    Weaver KD; Grossman SA; Herman JG
    Cancer Invest; 2006 Feb; 24(1):35-40. PubMed ID: 16466990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential sequences and single nucleotide polymorphism of exosomal SOX2 DNA in cancer.
    Vaidya M; Sugaya K
    PLoS One; 2020; 15(2):e0229309. PubMed ID: 32092088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosomal levels of miRNA-21 from cerebrospinal fluids associated with poor prognosis and tumor recurrence of glioma patients.
    Shi R; Wang PY; Li XY; Chen JX; Li Y; Zhang XZ; Zhang CG; Jiang T; Li WB; Ding W; Cheng SJ
    Oncotarget; 2015 Sep; 6(29):26971-81. PubMed ID: 26284486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential sequences of exosomal NANOG DNA as a potential diagnostic cancer marker.
    Vaidya M; Bacchus M; Sugaya K
    PLoS One; 2018; 13(5):e0197782. PubMed ID: 29787607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum exosomal miR-301a as a potential diagnostic and prognostic biomarker for human glioma.
    Lan F; Qing Q; Pan Q; Hu M; Yu H; Yue X
    Cell Oncol (Dordr); 2018 Feb; 41(1):25-33. PubMed ID: 29076027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alu methylation serves as a biomarker for non-invasive diagnosis of glioma.
    Chen J; Huan W; Zuo H; Zhao L; Huang C; Liu X; Hou S; Qi J; Shi W
    Oncotarget; 2016 May; 7(18):26099-106. PubMed ID: 27028997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating Cell-Free Nucleic Acids: Main Characteristics and Clinical Application.
    Szilágyi M; Pös O; Márton É; Buglyó G; Soltész B; Keserű J; Penyige A; Szemes T; Nagy B
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32957662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of free DNA quantification in serum and cerebrospinal fluid in glioma patients.
    Shi W; Lv C; Qi J; Zhao W; Wu X; Jing R; Wu X; Ju S; Chen J
    J Mol Neurosci; 2012 Mar; 46(3):470-5. PubMed ID: 21881830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating cell-free DNA as a prognostic and predictive biomarker in non-small cell lung cancer.
    Ai B; Liu H; Huang Y; Peng P
    Oncotarget; 2016 Jul; 7(28):44583-44595. PubMed ID: 27323821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exosomal noncoding RNAs in Glioma: biological functions and potential clinical applications.
    Cheng J; Meng J; Zhu L; Peng Y
    Mol Cancer; 2020 Mar; 19(1):66. PubMed ID: 32213181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating biomarkers for high-grade glioma.
    Loo HK; Mathen P; Lee J; Camphausen K
    Biomark Med; 2019 Feb; 13(3):161-165. PubMed ID: 30806515
    [No Abstract]   [Full Text] [Related]  

  • 18. Liquid biopsy: A new avenue in pathology.
    Ghosh RK; Pandey T; Dey P
    Cytopathology; 2019 Mar; 30(2):138-143. PubMed ID: 30485558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presence of Circulating miR-145, miR-155, and miR-382 in Exosomes Isolated from Serum of Breast Cancer Patients and Healthy Donors.
    Gonzalez-Villasana V; Rashed MH; Gonzalez-Cantú Y; Bayraktar R; Menchaca-Arredondo JL; Vazquez-Guillen JM; Rodriguez-Padilla C; Lopez-Berestein G; Resendez-Perez D
    Dis Markers; 2019; 2019():6852917. PubMed ID: 30891102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Immuno-Biochip Selectively Captures Tumor-Derived Exosomes and Detects Exosomal RNAs for Cancer Diagnosis.
    Yang Y; Kannisto E; Yu G; Reid ME; Patnaik SK; Wu Y
    ACS Appl Mater Interfaces; 2018 Dec; 10(50):43375-43386. PubMed ID: 30451486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.